D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 129 SEK -1.9% Market Closed
Market Cap: 2.1B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Other Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Devyser Diagnostics AB
Other Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Assets CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Other Assets
kr6.7m
CAGR 3-Years
205%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Other Assets
kr165.2m
CAGR 3-Years
215%
CAGR 5-Years
99%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Other Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Other Assets
kr9.9B
CAGR 3-Years
188%
CAGR 5-Years
87%
CAGR 10-Years
49%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Other Assets
kr9.7B
CAGR 3-Years
17%
CAGR 5-Years
31%
CAGR 10-Years
20%
BioArctic AB
STO:BIOA B
Other Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Devyser Diagnostics AB
Glance View

Market Cap
2.1B SEK
Industry
Biotechnology

Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. The company is headquartered in Hagersten, Stockholm. The company went IPO on 2021-12-10. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The firm has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The firm provides its products in more than 45 countries.

DVYSR Intrinsic Value
124.21 SEK
Overvaluation 4%
Intrinsic Value
Price
D

See Also

What is Devyser Diagnostics AB's Other Assets?
Other Assets
6.7m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Other Assets amounts to 6.7m SEK.

What is Devyser Diagnostics AB's Other Assets growth rate?
Other Assets CAGR 3Y
205%

Over the last year, the Other Assets growth was -1%. The average annual Other Assets growth rates for Devyser Diagnostics AB have been 205% over the past three years .

Back to Top